Loss of functional E-cadherin renders cells more resistant to the apoptotic agent taxol in vitro

Experimental Cell Research

Volumn 310, Issue 1, 2005, Pages 99-104

  Ferreira, Paulo ^a   Oliveira, Maria José ^a   Beraldi, Eliana ^b   Mateus, Ana Rita ^a   Nakajima, Takashi ^c   Gleave, Martin ^b   Yokota, Jun ^d   Carneiro, Fátima ^a,e   Huntsman, David ^b,f   Seruca, Raquel ^a,e   Suriano, Gianpaolo ^a,b,f  

^a UNIVERSITY OF PORTO   (Portugal)

^b VANCOUVER GENERAL HOSPITAL   (Canada)

^c GUNMA UNIVERSITY   (Japan)

^d NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^e HOSPITAL DE SÃO JOÃO   (Portugal)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Apoptosis; bcl 2; E cadherin; Germline mutations; HDGC

Indexed keywords

COLLAGEN TYPE 1; PACLITAXEL; PROTEIN BCL 2; UVOMORULIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CHO CELL; CONTROLLED STUDY; DRUG EFFECT; DRUG SENSITIVITY; FEMALE; GERM LINE; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STOMACH CANCER; WILD TYPE;

EID: 25844493033     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2005.07.010     Document Type: Article

References (21)

1. P.M. Comoglio, C. Boccaccio, and L. Trusolino Interactions between growth factor receptors and adhesion molecules: breaking the rules Curr. Opin. Cell Biol. 15 2003 565 571
2. E. Ruoslahti, and J.C. Reed Anchorage dependence, integrins, and apoptosis Cell 77 1994 477 488
3. S.M. Frisch, and E. Ruoslahti Integrins and anoikis Curr. Opin. Cell Biol. 9 1997 701 706
4. K.F. Becker, M.J. Atkinson, U. Reich, I. Becker, H. Nekarda, J.R. Siewert, and H. Hofler E-cadherin gene mutations provide clues to diffuse type gastric carcinomas Cancer Res. 54 1994 3845 3852
5. S.A. Gayther, K.L. Gorringe, S.J. Ramus, D. Huntsman, F. Roviello, N. Grehan, J.C. Machado, E. Pinto, R. Seruca, K. Halling, P. MacLeod, S.M. Powell, C.E. Jackson, B.A. Ponder, and C. Caldas Identification of germ-line E-cadherin mutations in gastric cancer families of European origin Cancer Res. 58 1998 4086 4089
6. P. Guilford, J. Hopkins, J. Harraway, M. McLeod, N. McLeod, P. Harawira, H. Taite, R. Scoular, A. Miller, and A.E. Reeve E-cadherin germline mutations in familial gastric cancer Nature 392 1998 402 405
7. J.C Machado, C. Oliveria, R. Carvalho, P. Soares, G. Berx, C. Caldas, R. Seruca, F. Carneiro, and M. Sobrinho-Simões E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma Oncogene 20 2001 1525 1528
8. E. Van Aken, O. De Wever, A.S. Correia da Rocha, and M. Mareel Defective E-cadherin/catenin complexes in human cancer Virchows Arch. 439 2001 725 751
9. J.P. Thiery Epithelial-mesenchymal transitions in tumour progression Nat. Rev., Cancer 2 2002 442 454
10. M. Mareel, and A. Leroy Clinical, cellular, and molecular aspects of cancer invasion Physiol. Rev. 83 2003 337 376
11. F. Carneiro, D.G. Huntsman, T.C. Smyrk, D.A. Owen, R. Seruca, P. Pharoah, C. Caldas, and M. Sobrinho-Simoes Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening J. Pathol. 203 2004 681 687
12. D.G. Huntsman, F. Carneiro, F.R. Lewis, P.M. MacLeod, A. Hayashi, K.G. Monaghan, R. Maung, R. Seruca, C.E. Jackson, and C. Caldas Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations N. Engl. J. Med. 344 2001 1942 1944
13. G. Suriano, C. Oliveira, P. Ferreira, J.C. Machado, M.C. Bordin, O. De Wever, E.A. Bruyneel, N. Moguilevsky, N. Grehan, T.R. Porter, F.M. Richards, R.H. Hruban, F. Roviello, D. Huntsman, M. Mareel, F. Carneiro, C. Caldas, and R. Seruca Identification of CDH1 germline missense mutations associated with functional inactivation of the E-cadherin protein in young gastric cancer probands Hum. Mol. Genet. 12 2003 575 582
14. G. Suriano, D. Mulholland, P. Ferreira, O. de Wever, C. Caldas, M. Mareel, J. Yokota, D. Huntsman, and R. Seruca The intracellular E-cadherin germline mutation V832 M lacks the ability to mediate cell-cell adhesion and to suppress invasion Oncogene 22 2003 5716 5719
15. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
16. G. Suriano, N. Vrcelj, J. Senz, P. Ferreira, H. Masoudi, K. Cox, S. Nabais, C. Lopes, J.C. Machado, R. Seruca, F. Carneiro, and D.G. Huntsman beta-Catenin (CTNNB1) gene amplification: a new mechanism of protein overexpression in cancer Genes Chromosomes Cancer 42 2005 238 246
17. G. Suriano, M.J. Oliveira, D. Huntsman, A.R. Mateus, P. Ferreira, F. Casares, C. Oliveira, F. Carneiro, J.C. Machado, M. Mareel, and R. Seruca E-cadherin germline missense mutations and cell phenotype: evidence for the independence of cell invasion on the motile capabilities of the cells Hum. Mol. Genet. 12 2003 3007 3016
18. K.N. Bhalla Microtubule-targeted anticancer agents and apoptosis Oncogene 22 2003 9075 9086
19. C.Y. Sasaki, H. Lin, and A. Passaniti Expression of E-cadherin reduces bcl-2 expression and increases sensitivity to etoposide-induced apoptosis Int. J. Cancer 86 2000 660 666
20. R.K. Srivastava, Q.S. Mi, J.M. Hardwick, and D.L. Longo Deletion of the loop region of Bcl-2 completely blocks paclitaxel-induced apoptosis Proc. Natl. Acad. Sci. U. S. A. 96 1999 3775 3780
21. E. Fricke, G. Keller, I. Becker, E. Rosivatz, C. Schott, S. Plaschke, M. Rudelius, C. Hermannstadter, R. Busch, H. Hofler, K.F. Becker, and B. Luber Relationship between E-cadherin gene mutation and p53 gene mutation, p53 accumulation, Bcl-2 expression and Ki-67 staining in diffuse-type gastric carcinoma Int. J. Cancer 104 2003 60 65